Project Details
Project Description
| Status | Active |
|---|---|
| Effective start/end date | 3/06/21 → 2/06/26 |
Keywords
- phase 1 and 2 study
- treatment safety
- treatment efficacy
- lymphoma
A Phase 1b/2, Open-Label Trial to Assess the Safety and Preliminary Efficacy of Epcoritamab in Combination with Other Agents in Subjects with B-cell Non-Hodgkin Lymphoma
- Gregory, Gareth (Primary Chief Investigator (PCI))
Project: Research